Issue of Equity

RNS Number : 5265Z
Deltex Medical Group PLC
16 March 2012
 



 
 
Deltex Medical Group plc

 

Issue of equity

 

 

16 March 2012 Deltex Medical Group plc ("Deltex Medical" or the "Company"), the global leader in oesophageal Doppler monitoring ("ODM"), announces that it has today issued a total of 889,624 new ordinary shares of 1p each in the Company ("New Ordinary Shares").

 

The Company has issued 112,402 New Ordinary Shares to a former employee of the Company as a final discharge of contractual commitments at an average price of 25.50 pence per share. The Company also announces that it has today issued a total of 570,685 New Ordinary Shares to several advisers of the Company at an average price of 25.50 pence per share.

 

In addition to the above, the Company was notified today that certain of its current employees and one ex-employee have acquired 206,537 ordinary shares of 1p each in the Company ("Ordinary Shares") as the result of the exercise of 206,537 options under the Company's 2003 Enterprise Management Incentive Scheme.

 

Accordingly, application has been made for these New Ordinary Shares to be admitted to trading on AIM. The shares rank pari passu with the existing issued shares of the Company and dealings are expected to commence on 22 March 2012.  Following the issue of these new shares the Company has a total of 142,988,989 ordinary shares of 1p each in issue.

 

 

 

For further information, please contact:-

 

Deltex Medical Group plc                                                                                01243 774 837
Nigel Keen, Chairman                                        
Ewan Phillips, Chief Executive                           
Paul Mitchell, Finance Director               

Nominated Adviser and Broker                                                                        0207 614 5917

Arden Partners plc 

Christopher Hardie

Jamie Cameron


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOESFUFEMFESEID
UK 100

Latest directors dealings